Clinical and Histologic Determinants of Renal Outcome in ANCA-Associated Vasculitis
Robert A.F. de Lind van Wijngaarden(Leiden University Medical Center), Ingeborg M. Bajema(University Medical Center Groningen), Franco Ferrario(Azienda Ospedaliera San Gerardo), David Jayne(University of Cambridge), Herbert A. Hauer(Leiden University Medical Center), Niels Rasmussen(University of Copenhagen), Gill Gaskin(Imperial College London), E. Christiaan Hagen(Leiden University Medical Center), Jan A. Bruijn(Leiden University Medical Center), Ron Wolterbeek(Leiden University Medical Center)
Cited by 259
Related Papers
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
|Arthritis & Rheumatism|2012|6.6k
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited
|Journal of the American Society of Nephrology|2004|2k
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
|New England Journal of Medicine|2010|1.7k
Pathologic Classification of Diabetic Nephropathy
|Journal of the American Society of Nephrology|2010|1.7k